These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20002304)

  • 1. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
    Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
    Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
    Tanaka H; El-Karef A; Kaito M; Kinoshita N; Fujita N; Horiike S; Watanabe S; Yoshida T; Adachi Y
    Liver Int; 2006 Apr; 26(3):311-8. PubMed ID: 16584393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis.
    Olmez OF; Gurel S; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):461-5. PubMed ID: 19940783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis.
    Tan TC; Crawford DH; Franklin ME; Jaskowski LA; Macdonald GA; Jonsson JR; Watson MJ; Taylor PJ; Fletcher LM
    Liver Int; 2012 Oct; 32(9):1391-9. PubMed ID: 22676252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
    Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
    Nadeem A; Hussain MM; Aslam M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):657-61. PubMed ID: 20943107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
    Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
    Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
    Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
    Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
    Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
    Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
    Bandara P; George J; McCaughan G; Naidoo D; Lux O; Salonikas C; Kench J; Byth K; Farrell GC
    Liver Int; 2005 Jun; 25(3):518-26. PubMed ID: 15910488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.